ADVISORY/Principal Investigator of GENESIS Network for Reproductive Health Presents Breakthrough Fertility Study Findings at World Congress Conference.

News Editors/Health/Medical Writers

ADVISORY...for Friday, June 4

--(BUSINESS WIRE)

 Study Offers New Hope for Increasing Pregnancy Success Rate for Women
                        in High-Risk Categories

              Paris Casino Resort -- Las Vegas -- June 4

WHY:          Up until now most couples rolled the dice, hoping
              in-vitro fertilization (IVF) would result in a baby. The
              emotional, financial and physical turmoil can be
              devastating. Thanks to a breakthrough fertility study,
              data now exists that will increase pregnancy success
              rates for women in high-risk categories such as women of
              advanced maternal age (38 years +) and those who suffer
              from recurrent pregnancy loss.

WHAT:         At the World Congress Conference, GENESIS Network for
              Reproductive Health's principal investigator will
              present findings from the world's first multi-centered,
              prospective, randomized study on the effects of PGD,
              titled "Preimplantation Genetic Diagnosis (PGD) as Both
              a Diagnostic and Therapeutic Tool in Assisted
              Reproductive Technology."

WHERE:        5th World Congress on Controversies in Obstetrics,
               Gynecology and Infertility
              Paris Casino & Resort
              3655 Las Vegas Boulevard
              Las Vegas, NV 89109

WHEN:         Friday, June 4, 2004 - 5:30 pm

WHO:          Dr. Werlin is the study's principal investigator, a
              world-renowned leader in the uses and study of PGD and
              the co-founder of GENESIS Network for Reproductive
              Health.

              According to Dr. Werlin, "These findings take the
              guessing game out of the process, giving couples across
              America the answers they have been waiting for. Our
              research now reveals how PGD can increase the chances
              for pregnancy success and minimize the emotional and
              financial toll too often associated with failed IVF
              cycles."

              PGD is gaining national and international attention for
              what it offers. PGD screens and tests for abnormal
              chromosomes in the beginning stages of in-vitro
              fertilization, offering valuable information early on
              for prospective parents about success rates and
              likelihood for passing on genetic diseases.

ABOUT
GENESIS:      GENESIS Network for Reproductive Health is comprised of
              a team of nationally noted, independent fertility
              specialists. Within the GENESIS Network is the Fertility
              Center of Las Vegas.

INTERVIEWS:   -- Pre-event interviews with Dr. Werlin can be arranged
                 by calling 714-573-0842
              -- Press attendance is also welcome and should be
                 confirmed in advance.

MEDIA
CONTACT:      To arrange an interview, call Kim Long at 714-573-0842
              or Christine Welch at 714-573-2744.